(a) For purposes of this section, “epinephrine autoinjector” means a single-use device used for the automatic injection of a premeasured dose of epinephrine into the human body.
(b) Carriers shall provide coverage for medically-necessary epinephrine autoinjectors for individuals who are 18 years of age or under.